Top compounds associated with response to SMAD4


Feature Type Standardized
Nominal ANOVA
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.21 8e-09
mRNA PF-184 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-08
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.24 6e-08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.18 1e-07
Download CSV